Syndax Pharmaceuticals Cash from Financing (TTM) Trends

Syndax Pharmaceuticals Inc (SNDX)

20.73 -0.54 (-2.54%) USD | NASDAQ | Apr 17, 16:00

20.73 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	264.13M
September 30, 2023	169.15M
June 30, 2023	153.78M
March 31, 2023	174.17M
December 31, 2022	172.25M
September 30, 2022	118.53M
June 30, 2022	133.76M
March 31, 2022	118.06M
December 31, 2021	118.46M
September 30, 2021	147.34M
June 30, 2021	147.40M
March 31, 2021	250.39M
December 31, 2020	304.42M
September 30, 2020	165.82M
June 30, 2020	164.14M
March 31, 2020	55.14M
December 31, 2019	28.57M
September 30, 2019	34.66M
June 30, 2019	44.04M
March 31, 2019	44.12M
December 31, 2018	15.73M

Date	Value
September 30, 2018	35.20M
June 30, 2018	26.74M
March 31, 2018	75.64M
December 31, 2017	75.72M
September 30, 2017	50.28M
June 30, 2017	50.99M
March 31, 2017	0.771M
December 31, 2016	54.20M
September 30, 2016	44.84M
June 30, 2016	103.19M
March 31, 2016	123.10M
December 31, 2015	77.27M
September 30, 2015	90.44M
June 30, 2015	39.90M
March 31, 2015	20.33M
December 31, 2014	12.41M
September 30, 2014	20.29M
June 30, 2014	17.25M
March 31, 2014	19.15M
December 31, 2013	20.89M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

28.57M

Minimum

Dec 2019

304.42M

Maximum

Dec 2020

145.49M

Average

147.40M

Median

Jun 2021

Cash from Financing (TTM) Benchmarks